AFEYAN NOUBAR

Director · Ten-percent owner · MRNA, GENB

As of 2026-09-17, AFEYAN NOUBAR has 117 Form 4 transactions on record across 2 companies — 116 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $2.5MIndirect: $47.6M$50.1Mas of 2026-09-17
  • Direct $2.5M
  • Indirect $47.6M
GENBindirect2,777,752 sh$47.6M
MRNAdirect12,908 sh$2.0M
GENBdirect29,561 sh$506K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

GENB · 109 trades
2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Purchase, 1,562,500 sh ($25.0M)2026-03-02: Conversion, 2,109,704 sh ($0)2026-03-02: Conversion, 17,016,215 sh ($0)2026-03-02: Conversion, 18,483,785 sh ($0)2026-03-02: Conversion, 2,531,644 sh ($0)2026-03-02: Conversion, 18,483,785 sh ($0)2026-03-02: Conversion, 17,016,215 sh ($0)2026-03-02: Conversion, 1,500,000 sh ($0)2026-03-02: Conversion, 843,881 sh ($0)2026-03-02: Conversion, 1,265,822 sh ($0)2026-03-02: Conversion, 2,953,586 sh ($0)2026-03-02: Conversion, 2,109,704 sh ($0)2026-03-02: Conversion, 2,531,644 sh ($0)2026-03-02: Conversion, 843,881 sh ($0)2026-03-02: Conversion, 1,500,000 sh ($0)2026-03-02: Conversion, 1,265,822 sh ($0)2026-03-02: Conversion, 2,953,586 sh ($0)2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 13,702,224 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 12,723,940 sh2026-03-02: Conversion, 987,491 sh2026-03-02: Conversion, 2,777,752 sh2026-03-02: Conversion, 2,777,752 sh2026-02-26: Award / grant, 29,561 sh ($0)2026-02-26: Award / grant, 29,561 sh ($0)
MRNA · 8 trades
2026-05-21: Sale, 9,263 sh ($434K)2026-05-21: Option exercise, 9,263 sh ($177K)2026-05-21: Option exercise, 9,263 sh ($0)2026-05-06: Award / grant, 12,908 sh ($0)2025-12-11: Sale, 23,853 sh ($703K)2025-12-11: Option exercise, 23,853 sh ($260K)2025-12-11: Option exercise, 23,853 sh ($0)2025-04-30: Award / grant, 25,512 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-05-21MRNASale9,263 @ $46.84$434K−70.2% of holding3,924Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0Mownership Δ n/a1,562,500Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0M+11.4% of holding15,264,724Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0M+56.3% of holding4,340,252Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0Mownership Δ n/a1,562,500Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0M+11.4% of holding15,264,724Form 4
2026-03-02GENBPurchase1,562,500 @ $16.00$25.0M+56.3% of holding4,340,252Form 4
2025-12-11MRNASale23,853 @ $29.48$703K−85.9% of holding3,924Form 4
109 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-21MRNAOption exercise9,26313,187Form 4
2026-05-21MRNAOption exercise9,2630Form 4
2026-05-06MRNAAward / grant12,90812,908Form 4
2026-03-02GENBConversion2,109,7040Form 4
2026-03-02GENBConversion17,016,2150Form 4
2026-03-02GENBConversion18,483,7850Form 4
2026-03-02GENBConversion2,531,6440Form 4
2026-03-02GENBConversion18,483,7850Form 4
2026-03-02GENBConversion17,016,2150Form 4
2026-03-02GENBConversion1,500,0000Form 4
2026-03-02GENBConversion843,8810Form 4
2026-03-02GENBConversion1,265,8220Form 4
2026-03-02GENBConversion2,953,5860Form 4
2026-03-02GENBConversion2,109,7040Form 4
2026-03-02GENBConversion2,531,6440Form 4
2026-03-02GENBConversion843,8810Form 4
2026-03-02GENBConversion1,500,0000Form 4
2026-03-02GENBConversion1,265,8220Form 4
2026-03-02GENBConversion2,953,5860Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion12,723,94012,723,940Form 4
2026-03-02GENBConversion13,702,22413,702,224Form 4
2026-03-02GENBConversion987,491987,491Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion12,723,94012,723,940Form 4
2026-03-02GENBConversion13,702,22413,702,224Form 4
2026-03-02GENBConversion987,491987,491Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion13,702,22413,702,224Form 4
2026-03-02GENBConversion12,723,94012,723,940Form 4
2026-03-02GENBConversion13,702,22413,702,224Form 4
2026-03-02GENBConversion987,491987,491Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4
2026-03-02GENBConversion12,723,94012,723,940Form 4
2026-03-02GENBConversion13,702,22413,702,224Form 4
2026-03-02GENBConversion987,491987,491Form 4
2026-03-02GENBConversion2,777,7522,777,752Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.